Business Daily Media

Men's Weekly

.

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

  • Written by ACN Newswire

NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3

- Trial achieved its primary endpoint of pathological Complete Response Rate- Trial achieved its secondary endpoint in operability (R0 rate)- NBTXR3 demonstrated significant superiority and clinical benefits for patients versus standard of care- Safety profile confirmed- Randomized trial validated the first-in-class mode of action of NBTXR3Paris,...

Time to punch above our weight and stop shadowboxing on AI

Australia prides itself on being an innovation economy. We celebrate startups, talk about productivity, and lean into our reputation for punching ...

Colter Bay Capital Launches as Australia’s Newest Institutional Private Credit Fund

Led by seasoned capital markets veteran Mark Wang, the fund is purpose-built to serve Australia’s most productive yet chronically underserved busi...

Global Thryv voices bring a sharper lens to International Women’s Day

Thryv® (NASDAQ: THRY), ANZ’s leading AI-enabled small business marketing software platform provider, marks International Women’s Day (IWD) with a bu...

AI curiosity fuels new wave of employee-led innovation in Australia

Leaders across Australia are asking themselves how they can ensure their employees get the most out of AI. We recently conducted research to help an...

Is your search bar your competitor’s best salesperson?

A few weeks ago, I was watching the Super Bowl. Traditionally, those halftime ad spots are reserved for the world’s biggest, most established bran...

AIIMS Group and AdVisible merge

Two of Australia’s most established independent agencies unite, creating marketing powerhouse backed by three decades of combined experience     ...